A Phase 1 Study of LY2584702 in Japanese Patients With Solid Tumors.

Trial Profile

A Phase 1 Study of LY2584702 in Japanese Patients With Solid Tumors.

Completed
Phase of Trial: Phase I

Latest Information Update: 20 May 2016

At a glance

  • Drugs LY 2584702 (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 20 May 2016 New source identified and integrated (Japan Pharmaceutical Information Center - Clinical Trials Information; JapicCTI101329)
    • 17 Nov 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 02 Sep 2011 Planned end date changed from 1 Nov 2010 to 1 Mar 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top